Leerink Partners Downgrades CymaBay Therapeutic (CBAY) to Market Perform
Tweet Send to a Friend
(Updated - February 20, 2024 8:59 AM EST)
Leerink Partners analyst Thomas J. Smith downgraded CymaBay Therapeutic (NASDAQ: CBAY) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Leerink Partners analyst Thomas J. Smith downgraded CymaBay Therapeutic (NASDAQ: CBAY) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
